Monaco F, Mutani R, Mastropaolo C, Tondi M
Epilepsia. 1979 Dec;20(6):705-10. doi: 10.1111/j.1528-1157.1979.tb04854.x.
Phenobarbital and carbamazepine concentrations were determined by the EMIT technique in tears, saliva, cerebrospinal fluid (CSF), and plasma of patients with epilepsy. Closer correlation was shown between tear/plasma and tear/CSF ratios than between saliva/plasma and saliva/CSF ratios for the two agents. The phenobarbital CSF/serum ratio was in good agreement with data in the literature, and the higher ratio found for carbamazepine may be caused by an EMIT assay cross-reaction for the free fraction of carbamazepine-10,11-epoxide. In our hands, tears seem to represent the best practical indicator of the unbound fraction of an anticonvulsant drug, and the noninvasiveness of the method makes it specifically useful in pediatric neurology.
采用EMIT技术测定癫痫患者眼泪、唾液、脑脊液(CSF)及血浆中苯巴比妥和卡马西平的浓度。对于这两种药物,泪液/血浆及泪液/脑脊液比值之间的相关性比唾液/血浆及唾液/脑脊液比值之间的相关性更为紧密。苯巴比妥的脑脊液/血清比值与文献数据吻合良好,卡马西平的比值较高可能是由于EMIT法对卡马西平-10,11-环氧化物游离部分的交叉反应所致。在我们的研究中,泪液似乎是抗惊厥药物游离部分的最佳实用指标,且该方法的非侵入性使其在小儿神经病学中特别有用。